250 related articles for article (PubMed ID: 14769395)
1. Relationship between CSF hypocretin levels and hypocretin neuronal loss.
Gerashchenko D; Murillo-Rodriguez E; Lin L; Xu M; Hallett L; Nishino S; Mignot E; Shiromani PJ
Exp Neurol; 2003 Dec; 184(2):1010-6. PubMed ID: 14769395
[TBL] [Abstract][Full Text] [Related]
2. Hypocretin-2-saporin lesions of the lateral hypothalamus produce narcoleptic-like sleep behavior in the rat.
Gerashchenko D; Kohls MD; Greco M; Waleh NS; Salin-Pascual R; Kilduff TS; Lappi DA; Shiromani PJ
J Neurosci; 2001 Sep; 21(18):7273-83. PubMed ID: 11549737
[TBL] [Abstract][Full Text] [Related]
3. The development of hypocretin (orexin) deficiency in hypocretin/ataxin-3 transgenic rats.
Zhang S; Lin L; Kaur S; Thankachan S; Blanco-Centurion C; Yanagisawa M; Mignot E; Shiromani PJ
Neuroscience; 2007 Aug; 148(1):34-43. PubMed ID: 17618058
[TBL] [Abstract][Full Text] [Related]
4. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
Nishino S; Kanbayashi T
Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
[TBL] [Abstract][Full Text] [Related]
5. Narcolepsy and the hypocretins.
Wurtman RJ
Metabolism; 2006 Oct; 55(10 Suppl 2):S36-9. PubMed ID: 16979425
[TBL] [Abstract][Full Text] [Related]
6. Effects of lateral hypothalamic lesion with the neurotoxin hypocretin-2-saporin on sleep in Long-Evans rats.
Gerashchenko D; Blanco-Centurion C; Greco MA; Shiromani PJ
Neuroscience; 2003; 116(1):223-35. PubMed ID: 12535955
[TBL] [Abstract][Full Text] [Related]
7. Survival rates through time of hypocretin grafted neurons within their projection site.
Arias-Carrión O; Drucker-Colín R; Murillo-Rodríguez E
Neurosci Lett; 2006 Aug; 404(1-2):93-7. PubMed ID: 16762505
[TBL] [Abstract][Full Text] [Related]
8. Hypocretin-2 saporin lesions of the ventrolateral periaquaductal gray (vlPAG) increase REM sleep in hypocretin knockout mice.
Kaur S; Thankachan S; Begum S; Liu M; Blanco-Centurion C; Shiromani PJ
PLoS One; 2009 Jul; 4(7):e6346. PubMed ID: 19623260
[TBL] [Abstract][Full Text] [Related]
9. Effects of hypocretin-saporin injections into the medial septum on sleep and hippocampal theta.
Gerashchenko D; Salin-Pascual R; Shiromani PJ
Brain Res; 2001 Sep; 913(1):106-15. PubMed ID: 11532254
[TBL] [Abstract][Full Text] [Related]
10. Effects of hypocretin/orexin cell transplantation on narcoleptic-like sleep behavior in rats.
Arias-Carrión O; Murillo-Rodríguez E
PLoS One; 2014; 9(4):e95342. PubMed ID: 24736646
[TBL] [Abstract][Full Text] [Related]
11. Effects of inflammation produced by chronic lipopolysaccharide administration on the survival of hypocretin neurons and sleep.
Gerashchenko D; Shiromani PJ
Brain Res; 2004 Sep; 1019(1-2):162-9. PubMed ID: 15306250
[TBL] [Abstract][Full Text] [Related]
12. Orexin-B-saporin lesions in the lateral hypothalamus enhance photic masking of rapid eye movement sleep in the albino rat.
Ocampo-Garcés A; Ibáñez F; Perdomo G; Torrealba F
J Sleep Res; 2011 Mar; 20(1 Pt 1):3-11. PubMed ID: 20626614
[TBL] [Abstract][Full Text] [Related]
13. Hypocretin deficiency in narcolepsy with cataplexy is associated with a normal body core temperature modulation.
Grimaldi D; Agati P; Pierangeli G; Franceschini C; Guaraldi P; Barletta G; Vandi S; Cevoli S; Plazzi G; Montagna P; Cortelli P
Chronobiol Int; 2010 Sep; 27(8):1596-608. PubMed ID: 20854137
[TBL] [Abstract][Full Text] [Related]
14. Orexin B/hypocretin 2 increases glutamatergic transmission to ventral tegmental area neurons.
Borgland SL; Storm E; Bonci A
Eur J Neurosci; 2008 Oct; 28(8):1545-56. PubMed ID: 18793323
[TBL] [Abstract][Full Text] [Related]
15. Effects of hypocretin (orexin) neuronal loss on sleep and extracellular adenosine levels in the rat basal forebrain.
Murillo-Rodriguez E; Liu M; Blanco-Centurion C; Shiromani PJ
Eur J Neurosci; 2008 Sep; 28(6):1191-8. PubMed ID: 18783368
[TBL] [Abstract][Full Text] [Related]
16. Normal cerebrospinal fluid levels of hypocretin-1 (orexin A) in patients with fibromyalgia syndrome.
Taiwo OB; Russell IJ; Mignot E; Lin L; Michalek JE; Haynes W; Xiao Y; Zeitzer JM; Larson AA
Sleep Med; 2007 Apr; 8(3):260-5. PubMed ID: 17369087
[TBL] [Abstract][Full Text] [Related]
17. Insomnia following hypocretin2-saporin lesions of the substantia nigra.
Gerashchenko D; Blanco-Centurion CA; Miller JD; Shiromani PJ
Neuroscience; 2006; 137(1):29-36. PubMed ID: 16289583
[TBL] [Abstract][Full Text] [Related]
18. The diurnal rhythm of hypocretin in young and old F344 rats.
Desarnaud F; Murillo-Rodriguez E; Lin L; Xu M; Gerashchenko D; Shiromani SN; Nishino S; Mignot E; Shiromani PJ
Sleep; 2004 Aug; 27(5):851-6. PubMed ID: 15453542
[TBL] [Abstract][Full Text] [Related]
19. Hypocretins (orexins): clinical impact of the discovery of a neurotransmitter.
Baumann CR; Bassetti CL
Sleep Med Rev; 2005 Aug; 9(4):253-68. PubMed ID: 15979356
[TBL] [Abstract][Full Text] [Related]
20. Narcolepsy in Parkinson's disease.
Haq IZ; Naidu Y; Reddy P; Chaudhuri KR
Expert Rev Neurother; 2010 Jun; 10(6):879-84. PubMed ID: 20518604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
